Combinations of glycopyrrolate and beta2 adrenoceptor agonists

Details for Australian Patent Application No. 2005244439 (hide)

Owner Novartis AG

Inventors Collingwood, Stephen Paul

Agent Davies Collison Cave

Pub. Number AU-B-2005244439

PCT Pub. Number WO2005/110402

Priority 0411056.5 18.05.04 GB

Filing date 17 May 2005

Wipo publication date 24 November 2005

Acceptance publication date 30 July 2009

International Classifications

A61K 31/402 (2006.01) - 1-aryl-substituted, e.g. piretanide

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/110402 Priority application(s): WO2005/110402

30 July 2009 Application Accepted

  Published as AU-B-2005244439

26 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005244440-Novel use of peptide compounds for treating dyskinesia

2005244438-Optical sensor for in vivo detection of analyte